Join academic, clinical, technology development and research stakeholders for a dialogue about emerging opportunities to treat hearing loss with therapeutics as well as new approaches for discovery, testing and treatment with the potential to rapidly accelerate therapeutic development.

Panelists and Themes
Clinical and surgical perspective
Dr. Daniel J. Lee, M.D., ENT Surgeon, Massachusetts Eye and Ear Infirmary; Associate Professor, Harvard Medical School

Patient perspective
Annahita Forghan, cochlear implant patient and PharmD student candidate

Research perspective
Dr. David P. Corey, Ph.D., Bertarelli Professor of Translational Medical Science, Harvard Medical School

Preclinical model and efficacy assessment
Celia Belline, CEO, CILcare

Safety assessment and combination product perspective
Peter M. Markham, CEO, CBSET

Intracochlear Drug Delivery (ICDD) device 
Dr. Jeffrey T. Borenstein, Ph.D., Draper Biomedical and Tissue Engineering